4//SEC Filing
RUDNICK SETH 4
Accession 0001562180-20-007477
CIK 0001560241other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 4:50 PM ET
Size
9.5 KB
Accession
0001562180-20-007477
Insider Transaction Report
Form 4
RUDNICK SETH
Director
Transactions
- Sale
Common Stock
2020-12-24$20.10/sh−924$18,572→ 5,266 total(indirect: See Footnote)
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price represents the weighted average price with a low of $20.08 and a high of $20.12. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.
- [F3]These shares are held in the Seth A. Rudnick 2014 GST Trust U/A Dated 03/01/2014 (the "Trust") for the benefit of the Reporting Person's heirs. The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001184420
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 4:50 PM ET
- Size
- 9.5 KB